All News

Specialty pharmacy is big and getting bigger. Some even call it a gold rush. Here are tips for those who'd like a piece of the action.

Joining 12 other states and the U.S. military, Ohio will reclassify tramadol and products containing tramadol as Schedule IV controlled substances effective September 1, 2014.

Some families run to redheads. Some families witness a series of multiple births over a couple of generations. But a flock of pharmacists? Would that be nature, nurture, or morphic resonance?

Sandoz, the generic pharmaceuticals division of Novartis, has introduced an authorized generic version of Diovan (valsartan) tablets for the treatment of hypertension. The generic version of Diovan will be available in 40 mg, 80 mg, 160 mg, and 320 mg strength tablets, the same strength as the branded version.

FDA has approved another treatment for patients with peripheral T-cell lymphoma (PTCL), a rare yet aggressive type of non-Hodgkin lymphoma. Belinostat (Beleodaq) by Spectrum Pharmaceuticals was approved under FDA’s accelerated approval program. It is indicated for patients with relapsed or refractory PTCL.

During the American Society of Health-System Pharmacists’ upcoming 2014 Midyear Clinical Meeting and Exhibition in Anaheim, CA., a so-called Intelligent Pharmacy Pavilion (IPP) featuring demonstration rooms with the latest technology for hospital and ambulatory care pharmacies will be showcased.

A new survey indicates that pharmacists, nurses, and other practitioners believe IV insulin and anticoagulants should be considered the medications that can cause the most harm when used improperly.

The misuse of single-dose and multiple-dose vials has harmed thousands of patients, in some cases causing bloodborne pathogens including hepatitis B and C, meningitis, and epidural abscesses, according to the Centers for Disease Control and Prevention.

A bill that would authorize California pharmacists to dispense naloxone hydrochloride, a drug used to reverse opiate overdoses, has cleared several legislative hurdles.

We all know that electronic prescriptions solved all those script communication problems between prescribers and pharmacists, right? Well, the Cynical Pharmacist dispelled any such myths in his blog “Electronic prescriptions: Return to sender.” It was our most-read story of June.